SEC Form 4 · accession 0001127602-17-033783
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Alexander Ingram
Director
Period of report
Dec 1, 2017
Accepted (ET)
Dec 4, 2017 · 3:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 1, 2017 | A | 3,690 | $5.08 | A | 15,130 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750.